Novartis è quotata al NYSE e alla Borsa di Zurigo ed è presente, con i propri prodotti, in oltre 180 Paesi del mondo. É attiva anche in Italia, dove ha headquarter ad Origgio, presso Varese ...

A Phase 2, Adaptive, Randomized, Open-label, Assessor-blinded Active-controlled Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Standard of Care in Patients Suffering From ...

Novartis AG’s plan to sell its 70.6% stake in Novartis India is on track, CEO Vas Narasimhan confirmed at the World Economic Forum in Davos. Speaking to CNBC-TV18, he emphasised the company’s ...

A Google parent-owned startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end, marking a significant milestone in pharmaceutical development as ...

Con il suo inserimento nello scacchiere bianconero Motta avrà parecchie soluzioni tattiche in più in attacco, grazie alla duttilità e alla capacità di ricoprire più ruoli del 26enne.

Greece on Monday prosecuted a pair of protected witnesses for alleged perjury in a long-running bribery probe involving the Swiss pharmaceutical firm Novartis, a justice source said. The man and woman ...

“Stepping into the sacred aura of Mahadev for #Kannappa. Honored to bring this epic tale to life. May Lord Shiva guide us on this divine journey. Om Namah Shivaya!” read the caption for Kumar’s post ...

Vishnu Manchu’s ‘Kannappa’ teaser: Makers reveal glimpse of Mohanlal, Prabhas and Akshay Kumar In the poster, Akshay Kumar is seen as Lord Shiva, carrying a trident and a drum, symbols of ...

Makers of Kannappa released Akshay Kumar's first look poster featuring him as Lord Shiva This is the second time that Akshay plays Lord Shiva on-screen Kannappa is set for a grand release on April 25 ...

Vishnu Manchu's film 'Kannappa', set for release on April 25, 2025, features Akshay Kumar as Lord Shiva and Kajal Aggarwal as Parvathi Devi. The film narrates the tale of Kannappa Nayannar ...

Novartis won an order from a U.S. appeals court in Washington on Thursday temporarily blocking MSN Pharmaceuticals from launching a generic version of Novartis' heart-failure drug Entresto, per a ...